Quest Diagnostics Incorporated Stock Analysis

DGX Stock  USD 163.59  0.30  0.18%   
Quest Diagnostics Incorporated is overvalued with Real Value of 145.95 and Target Price of 146.31. The main objective of Quest Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Quest Diagnostics Incorporated is worth, separate from its market price. There are two main types of Quest Diagnostics' stock analysis: fundamental analysis and technical analysis.
The Quest Diagnostics stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Quest Diagnostics is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Quest Stock trading window is adjusted to America/New York timezone.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Quest Stock Analysis Notes

About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 60.8. The company has Price/Earnings To Growth (PEG) ratio of 1.91. Quest Diagnostics recorded earning per share (EPS) of 7.44. The entity last dividend was issued on the 14th of January 2025. The firm had 2:1 split on the 21st of June 2005. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people. To learn more about Quest Diagnostics Incorporated call Stephen Rusckowski at 973 520 2700 or check out https://www.questdiagnostics.com.

Quest Diagnostics Quarterly Total Revenue

2.49 Billion

Quest Diagnostics Investment Alerts

Quest Diagnostics has a strong financial position based on the latest SEC filings
Over 92.0% of the company shares are held by institutions such as insurance companies
On 21st of October 2024 Quest Diagnostics paid $ 0.75 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: 6.1 Bn Dietary Supplement Testing Services Global Market Opportunities and Strategies to 2033 Contaminant Testing Platforms, Adulteration Panel Analysis, AI-Driven Platforms for Improved Testing

Quest Diagnostics Upcoming and Recent Events

Earnings reports are used by Quest Diagnostics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
1st of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Quest Largest EPS Surprises

Earnings surprises can significantly impact Quest Diagnostics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2000-04-24
2000-03-310.090.10.0111 
2000-01-27
1999-12-310.050.060.0120 
1999-01-27
1998-12-310.040.050.0125 
View All Earnings Estimates

Quest Diagnostics Environmental, Social, and Governance (ESG) Scores

Quest Diagnostics' ESG score is a quantitative measure that evaluates Quest Diagnostics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Quest Diagnostics' operations that may have significant financial implications and affect Quest Diagnostics' stock price as well as guide investors towards more socially responsible investments.

Quest Diagnostics Thematic Classifications

In addition to having Quest Diagnostics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Quest Stock Institutional Investors

Shares
Amvescap Plc.2024-06-30
1.8 M
Goldman Sachs Group Inc2024-06-30
1.7 M
Jpmorgan Chase & Co2024-06-30
1.5 M
Wells Fargo & Co2024-06-30
1.5 M
Fiduciary Management, Inc. Of Milwaukee2024-09-30
1.4 M
Norges Bank2024-06-30
1.3 M
Fmr Inc2024-09-30
1.1 M
Northern Trust Corp2024-09-30
M
Legal & General Group Plc2024-06-30
959.6 K
Vanguard Group Inc2024-09-30
14 M
Blackrock Inc2024-06-30
10.1 M
Note, although Quest Diagnostics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Quest Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 18.26 B.

Quest Profitablity

The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.17  0.14 
Return On Capital Employed 0.10  0.10 
Return On Assets 0.06  0.04 
Return On Equity 0.14  0.08 

Management Efficiency

Quest Diagnostics has Return on Asset of 0.0566 % which means that on every $100 spent on assets, it made $0.0566 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1322 %, implying that it generated $0.1322 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2024. Return On Capital Employed is likely to drop to 0.10 in 2024. At this time, Quest Diagnostics' Other Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.99 in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 57.30  60.17 
Tangible Book Value Per Share(22.15)(21.04)
Enterprise Value Over EBITDA 11.62  7.35 
Price Book Value Ratio 2.45  3.00 
Enterprise Value Multiple 11.62  7.35 
Price Fair Value 2.45  3.00 
Enterprise Value9.7 B10.2 B
At Quest Diagnostics, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Dividend Yield
0.0183
Operating Margin
0.1419
Profit Margin
0.0882
Forward Dividend Yield
0.0183
Beta
0.891

Technical Drivers

As of the 25th of November, Quest Diagnostics holds the Coefficient Of Variation of 1062.14, semi deviation of 0.8942, and Risk Adjusted Performance of 0.0761. Quest Diagnostics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.

Quest Diagnostics Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Quest Diagnostics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Quest Diagnostics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Quest Diagnostics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quest Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quest Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Quest Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Quest Diagnostics Outstanding Bonds

Quest Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Quest Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Quest bonds can be classified according to their maturity, which is the date when Quest Diagnostics Incorporated has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Quest Diagnostics Predictive Daily Indicators

Quest Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Quest Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Quest Diagnostics Corporate Filings

F4
7th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
30th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
25th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
23rd of October 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
22nd of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
3rd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
26th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
3rd of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Quest Diagnostics Forecast Models

Quest Diagnostics' time-series forecasting models are one of many Quest Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Quest Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Quest Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Quest Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Quest shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Quest Diagnostics. By using and applying Quest Stock analysis, traders can create a robust methodology for identifying Quest entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.12  0.09 
Operating Profit Margin 0.14  0.10 
Net Profit Margin 0.09  0.05 
Gross Profit Margin 0.32  0.44 

Current Quest Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Quest analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Quest analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
146.31Buy18Odds
Quest Diagnostics Incorporated current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Quest analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Quest stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Quest Diagnostics, talking to its executives and customers, or listening to Quest conference calls.
Quest Analyst Advice Details

Quest Stock Analysis Indicators

Quest Diagnostics Incorporated stock analysis indicators help investors evaluate how Quest Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Quest Diagnostics shares will generate the highest return on investment. By understating and applying Quest Diagnostics stock analysis, traders can identify Quest Diagnostics position entry and exit signals to maximize returns.
Begin Period Cash Flow315 M
Long Term Debt4.4 B
Common Stock Shares Outstanding113 M
Total Stockholder Equity6.3 B
Tax Provision204 M
Quarterly Earnings Growth Y O Y0.015
Property Plant And Equipment Net2.4 B
Cash And Short Term Investments686 M
Cash686 M
Accounts Payable378 M
Net Debt4.7 B
50 Day M A154.8402
Total Current Liabilities1.8 B
Other Operating ExpensesB
Non Current Assets Total11.7 B
Forward Price Earnings16.6113
Non Currrent Assets Other198 M
Stock Based Compensation77 M

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.